biopharma
Symeres announces acquisition of DGr Pharma
September 11, 2025Medical Communications, Research and Development DGr Pharma, Symeres, biopharma, contract research
Symeres, a Contract Research, Development and Manufacturing Organization (CRDMO) has acquired DGr Pharma, a drug development-focused consultancy. The acquisition will …
Brian Adams appointed as Kymera’s CLO and Corporate Secretary
September 11, 2025Kymera, biopharma, corporate, immunology
Brian Adams has been appointed as Kymera Therapeutics’ Chief Legal Officer (CLO) and Corporate Secretary. He will lead Kymera’s legal, …
Mallia strengthens its advisory board as it accelerates hair loss treatment
July 7, 2025Manufacturing and Production Dermatology, Skin, biopharma, dermatology, hair loss, mallia
German dermatology company, Mallia Innovations, has appointed Jens Holstein, Alexandra Ogilvie and Ulrich Dauer to its advisory board, strengthening its …
BioPhorum appoints Uwe Buecheler as non-executive director
May 21, 2025Medical Communications, Research and Development BioPhorum, Corporate, appointment, biopharma, medical communication
BioPhorum has announced the appointment of Uwe Buecheler as a non-executive director to its board. The company brings together leaders …
Hansa Biopharma appoints Maria Törnsén as chief operating officer and US president
May 14, 2025Research and Development Corporate, Hansa Biopharma, Immunology, Pharmacy, biopharma, chief operating officer (COO), immunology
Swedish biopharma company Hansa Biopharma has appointed Maria Törnsén as chief operating officer (COO) and president US effective 19 May …
Donato Spota appointed as chief financial officer at Eleva
May 14, 2025Research and Development Eleva, Pharmacy, appointment, biopharma, chief financial officer (CFO)
German biopharma company, Eleva, has appointed Donato Spota as its new chief financial officer (CFO) and managing director to support …
University of Edinburgh spinout Kynos Therapeutics acquired by Dr. Falk Pharma
October 30, 2024Research and Development Edinburgh, Internal Medicine, Microbiology, acquisitions, biopharma, inhibitors
Kynos Therapeutics – a Scottish clinical stage biopharma company focusing on developing novel kynurenine 3-monooxygenase (KMO) inhibitors – has been …
Contract manufacturing services industry set to grow at CAGR of 10.6% between 2017-2027
June 19, 2019Research and Development EU, Europe, biopharma, contract manufacturing services, manufacturing, pharma
The biopharmaceutical contract manufacturing market is expected to grow at a compound annual growth rate (CAGR) of 10.6% between 2017 …
Merck Serono in $826m immuno-oncology deal
March 31, 2015Research and Development, Sales and Marketing Intrexon, Merck, Merck Serono, T cell, biopharma, cart, immuno-oncology, t-cell
Merck Serono has announced a significant deal with Intrexon to develop and bring new cancer treatments to market. The German …
Baxter to split in two next year
March 28, 2014Medical Communications, Research and Development, Sales and Marketing AbbVie, Abbott, baxter, biopharma, gambro
Baxter is taking a plunge into the world of restructuring by splitting into two entities: one which is yet to …
Pharma creates non-profit R&D organisation
September 21, 2012Research and Development, Sales and Marketing Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Co, GlaxoSmithKline, Johnson & Johnson, Pfizer, R&D, Roche Genentech, Sanofi, TransCelerate BioPharma, biopharma
Ten biopharma companies have formed TransCelerate BioPharma Inc, a not-for-profit organisation using money and personnel from each firm, with a …
Significant reorganisation for Chelsea Therapeutics
July 11, 2012Research and Development, Sales and Marketing Chelsea Therapeutics, Northera, biopharma, biotech
Biopharma development firm Chelsea Therapeutics has announced a major corporate reorganisation. The move includes a significant reduction in headcount, the …
